Surgify Aims for Growth with Multi-Million Euro Investment
We advised the European Innovation Council Fund (EIC Fund) in connection with a €7 million funding round in Surgify Medical Oy.
Surgify Medical Oy is a surgical technology company based in Helsinki, Finland, founded in 2017. The company is developing advanced bone surgery technology designed to protect soft tissues and prevent complications during procedures. Its flagship innovation is a patented drill system that stops automatically upon contact with soft tissue, thereby increasing surgical safety in areas such as the head, neck, and spine.
The funds raised in this round will support Surgify’s growth and international expansion, including entry into the United States market. The funding round was led by ZEISS Ventures and also included the EIC Fund, along with existing investors Lednil and Cascara Ventures.
This transaction is part of the long-term collaboration agreement between Eversheds Sutherland and the EIC Fund.
Our advisory team consisted of Partner Antti Husa, Partner Saara Kyhälä, Senior Associate Lavinia Husa, Associate Fanny Ilveskero, Associate Sanni Tirkkonen, and Trademark Attorney Carina Bergroth.
Read more in Talouselämä.
Key contacts
Antti Husa
Attorney-at-Law, Partner
Antti Husa has been involved in over a hundred different corporate arrangements, ranging from assisting seed rounds of growth companies to IPOs. He actively serves as an advisor to both sellers and buyers in corporate transactions, and he also participates in the board work of several client companies as a board expert member and secretary.
Expertise includes
Private M&A
Venture Capital Transactions
Corporate and company law
Commercial agreements
Restructuring and Insolvency